Luogo: Università di Milano Bicocca, | Città: Milano, Italia
16-18 marzo 2017
2nd Liver Immunology Meeting AISF and SIICA
Università di Milano Bicocca, Piazza dell'Ateneo Nuovo 1, Milano
P. Invernizzi | San Gerardo Hospital, Monza, and University of Milan-Bicocca, Milan, Italy
G. Missale | University Hospital of Parma, Parma, Italy
Liver inflammation in HBV
A. Bertoletti| Institute for Clinical Sciences, Singapore
C. Garlanda |Humanitas Clinical and Research Center, Milano, Italy
D.Mavilio |University of Milan, Milan, and Humanitas Clinical and Research Center, Rozzano, Italy
I.N. Crispe| University of Washington, Seattle, WA, USA
L. Guidotti| The Scripps Research Institute, La Jolla, CA, USA and San Raffaele Scientific Institute, Milan, Italy
L. Fabris|University of Padua, Padua, Italy and University of Yale, Yale, CT, USA
D. Adams| University of Birmingham, Birmingham, UK
A. Moschetta | University of Bari, Bari, Italy
F. Marra | University of Firenze, Firenze, Italy
M. Molgora | IL-1R8: a novel checkpoint regulating anti-tumoranti-viral activity of NK cells
A. Bènèchet | Spatiotemporal dynamics of naïve CD8+ T cells undergoing intrahepatic priming
S. Bruzzì | Role of cx3cr1 in the differentiation of monocyte-derived inflammatory dendritic cells in response to hepatic injury
h. 12:45 Lunch and poster viewing
M. Mondelli| University of Pavia, Pavia, Italy
S. Abrignani | Istituto di Genetica Molecolare, Milan, Italy
M. Maini | University College London, London, UK
C. Ferrari| University Hospital of Parma, Parma, Italy
A. Folgori|Okairos, Rome, Italy
R. Thimme|University Hospital Freiburg, Freiburg, Germany
V. Barnaba | University of Rome La Sapienza, Rome, Italy
G. Missale| University Hospital of Parma, Italy
I. Melero | CIMA, CUN and Medical School, University of Navarra, Pamplona, Spain
V. Racanelli | University of Bari, Bari, Italy
M. Visentini | Reversion of B-cell anergy in patients with Hepatitis C virus-associated mixed cryoglobulinemia after removal of chronic antigen stimulation – a model of human reversible peripheral B cell anergy?
E. Cariani | Prognostic correlates of the immune microenvironment of hepatocellular carcinomasurrounding liver
E. Riboldi | Role of CLEC4D in inflammation-driven liver carcinogenesis
E. Krawitt | University of Vermont, Burlington, VT, USA
A. Tanaka | Teikyo University, Tokyo, Japan
X. Ma | Shanghai Institute of Digestive Disease, Shanghai, China
H. Young| National Institute of Health, Bethesta, MD, USA
M.E. Gershwin | University of California, Davis, CA, USA
M. Carbone | San Gerardo Hospital, Monza, and University of Milan-Bicocca, Milan, Italy
C. Schramm| University of Hamburg, Hamburg, Germany
C. Bowlus | University of California, Davis, CA, US
M. B. Violatto | NP-dependent administration of dexamethasone prevents its systemic spreadreduces inflammatory markers in a murine model of autoimmune hepatitis.
S. Pang | Prevalence of autoimmune liver disease-related autoantibodies in patients with biliary artesia
A. Gerussi | Incomplete normalization of transaminases at 18 months is the most important predictor for biochemical response
h. 12:35 Round table: Novel therapeutic approaches for pediatric and adult autoimmune liver diseases
P. Invernizzi | San Gerardo Hospital, Monza, and University of Milan-Bicocca, Milan, Italy
A. Floreani | University of Padua, Padua, Italy
L. Muratori | University of Bologna, Bologna, Italy
A. Tanaka | Teikyo University, Tokyo, Japan
A. Biondi | University of Milan-Bicocca, Milan, Italy
Gut-liver axis in liver disease
M. Rescigno | IFOM-IEO, Istituto Europeo di Oncologia and University of Milano, Milan, Italy
Powered by iCagenda